Acadia pharmaceuticals reports inducement grants under nasdaq listing rule 5635(c)(4)

San diego--(business wire)--acadia pharmaceuticals inc. (nasdaq: acad) today announced that on august 1, 2023, the compensation committee of acadia's board of directors (the “committee”) granted inducement awards consisting of non-qualified stock options to purchase 40,612 shares of common stock and 14,990 restricted stock units (“rsus”) to 16 new employees under acadia's 2023 inducement plan. the compensation committee approved the awards as an inducement material to the new employees' employm.
ACAD Ratings Summary
ACAD Quant Ranking